Represents adjusted earnings before interest expense, income taxes, depreciation and amortization, LIFO adjustments, facility closing and impairment, inventory write-downs related to store closings, debt retirements and other items from continuing operations.

No definition available.

+ Details

Name:	rad_AdjustedEarningsBeforeInterestIncomeTaxesDepreciationAndAmortizationFromContinuingOperations
Namespace Prefix:	rad_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

+ Details

Name:	us-gaap_GrossProfit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130543-203045

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130539-203045

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=rad_RetailPharmacyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=rad_PharmacyServicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Segment Reporting (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Segment Reporting (Details) - USD ($) $ in Thousands	Mar. 02, 2019	Dec. 01, 2018	Sep. 01, 2018	Jun. 02, 2018	Mar. 03, 2018	Dec. 02, 2017	Sep. 02, 2017	Jun. 03, 2017	Mar. 02, 2019	Mar. 03, 2018	Mar. 04, 2017
Segment Reporting
Revenues	$ 5,379,645	$ 5,450,060	$ 5,421,362	$ 5,388,490	$ 5,394,264	$ 5,353,170	$ 5,345,011	$ 5,436,523	$ 21,639,557	$ 21,528,968	$ 22,927,540
Gross Profit									4,676,352	4,780,105	5,064,707
Adjusted EBITDA									563,444	559,854	747,888
Retail Pharmacy
Segment Reporting
Revenues									15,757,152	15,832,625	16,766,620
Pharmacy Services
Segment Reporting
Revenues									6,093,688	5,896,669	6,393,884
Operating segments \| Retail Pharmacy
Segment Reporting
Revenues									15,757,152	15,832,625	16,766,620
Gross Profit									4,258,716	4,372,373	4,671,975
Adjusted EBITDA									405,206	388,320	559,653
Operating segments \| Pharmacy Services
Segment Reporting
Revenues									6,093,688	5,896,669	6,393,884
Gross Profit									417,636	407,732	392,732
Adjusted EBITDA									158,238	171,534	188,235
Intersegment elimination
Segment Reporting
Revenues									$ (211,283)	$ (200,326)	$ (232,964)